Precision AQ

Precision AQ is a commercialization partner for pharmaceutical and biotech clients, working across a product's entire lifecycle from early pipeline through post-launch optimization. The firm integrates technology, expertise and strategic guidance to help biopharma innovators, market access leaders and brand strategists bring products to market. It has supported launches and label expansions for a significant portion of FDA-approved drugs.

The company's work spans several practice areas. Value and Access services help clients secure access to medicines and are led in part by former access decision-makers. Medical Communications is delivered by clinicians, scientists and communications professionals. Other services include investor relations, brand strategy and marketing for pharmaceutical and biotech brands, and data solutions built around data integration, with the stated aim of turning data chaos into clarity.

Precision AQ employs over 1,200 experts across the globe, drawn from roles including former access decision-makers, clinicians, scientists, strategists and communications professionals. The firm describes its approach as combining data with human insight, positioning itself as "where IQ meets EQ", and its teams as architects of leading solutions that open new pathways for life-changing medicine. Its client base sits within pharmaceuticals, biotechnology, biopharma, life sciences and healthcare market access.